Home

érint csomag gitt acs stent Elavult borjú Intarzia

Coating stents with vitamin C could reduce clotting risks - American  Chemical Society
Coating stents with vitamin C could reduce clotting risks - American Chemical Society

Ticagrelor Versus Clopidogrel in Patients with Late or Very Late Stent  Thrombosis | SpringerLink
Ticagrelor Versus Clopidogrel in Patients with Late or Very Late Stent Thrombosis | SpringerLink

5 Pearls on Dual Antiplatelet Therapy (DAPT) | Core IM Podcast
5 Pearls on Dual Antiplatelet Therapy (DAPT) | Core IM Podcast

5 Pearls on Dual Antiplatelet Therapy (DAPT) | Core IM Podcast
5 Pearls on Dual Antiplatelet Therapy (DAPT) | Core IM Podcast

A Senolytic-Eluting Coronary Stent for the Prevention of In-Stent  Restenosis | ACS Biomaterials Science & Engineering
A Senolytic-Eluting Coronary Stent for the Prevention of In-Stent Restenosis | ACS Biomaterials Science & Engineering

A Senolytic-Eluting Coronary Stent for the Prevention of In-Stent  Restenosis | ACS Biomaterials Science & Engineering
A Senolytic-Eluting Coronary Stent for the Prevention of In-Stent Restenosis | ACS Biomaterials Science & Engineering

STOPDAPT-2 ACS trial inconclusive for 1- vs. 12-month DAPT after PCI and  DES implantation
STOPDAPT-2 ACS trial inconclusive for 1- vs. 12-month DAPT after PCI and DES implantation

Interface Engineering of Fully Metallic Stents Enabling Controllable H2O2  Generation for Antirestenosis | Langmuir
Interface Engineering of Fully Metallic Stents Enabling Controllable H2O2 Generation for Antirestenosis | Langmuir

Acute coronary syndrome due to very late stent thrombosis 3 years after...  | Download Scientific Diagram
Acute coronary syndrome due to very late stent thrombosis 3 years after... | Download Scientific Diagram

Acute Coronary Syndrome – Explained By A Cardiologist • MyHeart
Acute Coronary Syndrome – Explained By A Cardiologist • MyHeart

JCM | Free Full-Text | Clinical Outcomes of Different Calcified Culprit  Plaques in Patients with Acute Coronary Syndrome
JCM | Free Full-Text | Clinical Outcomes of Different Calcified Culprit Plaques in Patients with Acute Coronary Syndrome

Three-Month DAPT Non-Inferior for ACS Patients Treated With Combo Dual  Therapy Stent | DAIC
Three-Month DAPT Non-Inferior for ACS Patients Treated With Combo Dual Therapy Stent | DAIC

Drug-Eluting Stents | Circulation
Drug-Eluting Stents | Circulation

DAY 3 - Acute Coronary Syndromes — The Intern at Work
DAY 3 - Acute Coronary Syndromes — The Intern at Work

Polymer-free drug-eluting stents — a safe and effective option for ACS |  Nature Reviews Cardiology
Polymer-free drug-eluting stents — a safe and effective option for ACS | Nature Reviews Cardiology

Prevalence, Morphology, and Predictors of Intra-Stent Plaque Rupture in  Patients with Acute Coronary Syndrome: An Optical Coherence Tomography  Study - Huai Yu, Jiannan Dai, Chao Fang, Senqing Jiang, Gary S. Mintz, Bo
Prevalence, Morphology, and Predictors of Intra-Stent Plaque Rupture in Patients with Acute Coronary Syndrome: An Optical Coherence Tomography Study - Huai Yu, Jiannan Dai, Chao Fang, Senqing Jiang, Gary S. Mintz, Bo

Use of drug-eluting versus bare-metal stents after an acute coronary  syndrome in Portugal: The EURHOBOP study | Revista Portuguesa de  Cardiologia (English edition)
Use of drug-eluting versus bare-metal stents after an acute coronary syndrome in Portugal: The EURHOBOP study | Revista Portuguesa de Cardiologia (English edition)

Frontiers | Optimal Strategy for Antiplatelet Therapy After Coronary  Drug-Eluting Stent Implantation in High-Risk “TWILIGHT-like” Patients With  Diabetes Mellitus
Frontiers | Optimal Strategy for Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation in High-Risk “TWILIGHT-like” Patients With Diabetes Mellitus

Duration of Dual Anti-Platelet Therapy After Percutaneous Coronary  Intervention With Drug-Eluting Stents | SCAI
Duration of Dual Anti-Platelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents | SCAI

Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing  Complex Percutaneous Coronary Intervention | Circulation: Cardiovascular  Interventions
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing Complex Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions

Duration of dual antiplatelet therapy after percutaneous coronary  intervention with drug-eluting stent: systematic review and network  meta-analysis | The BMJ
Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis | The BMJ

SOLACI | Latin American Society of Interventional Cardiology
SOLACI | Latin American Society of Interventional Cardiology

JCM | Free Full-Text | Antiplatelet Therapy in Coronary Artery Disease: A  Daunting Dilemma
JCM | Free Full-Text | Antiplatelet Therapy in Coronary Artery Disease: A Daunting Dilemma

Risk of Elective Major Noncardiac Surgery After Coronary Stent Insertion |  tctmd.com
Risk of Elective Major Noncardiac Surgery After Coronary Stent Insertion | tctmd.com

Angioplasty and stent placement - heart - SmartEngage
Angioplasty and stent placement - heart - SmartEngage

Flow chart. ACS, acute coronary syndrome; LST, late stent thrombosis;... |  Download Scientific Diagram
Flow chart. ACS, acute coronary syndrome; LST, late stent thrombosis;... | Download Scientific Diagram